Advertisement

Topics

Essential medicines availability is still suboptimal in many countries: A scoping review.

07:00 EST 13th February 2018 | BioPortfolio

Summary of "Essential medicines availability is still suboptimal in many countries: A scoping review."

To identify uses of WHO Model list of essential medicines (EM) and summarize studies examining essential medicines (EM) and national EM lists (NEMLs).

Affiliation

Journal Details

This article was published in the following journal.

Name: Journal of clinical epidemiology
ISSN: 1878-5921
Pages:

Links

DeepDyve research library

PubMed Articles [9428 Associated PubMed Articles listed on BioPortfolio]

Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.

Access to essential medicines in pediatric endocrinology and diabetes is limited in resource-limited countries. The World Health Organization (WHO) maintains two non-binding lists of essential medicin...

Essential medicines for emergency care in Africa.

Essential medicines lists (EMLs) are efficient means to ensure access to safe and effective medications. The WHO has led this initiative, generating a biannual EML since 1977. Nearly all countries hav...

Service Readiness For Noncommunicable Diseases Was Low In Five Countries In 2013-15.

The growing burden of noncommunicable diseases (NCDs) may pose challenges for resource-limited health systems. This study used standardized, nationally representative data from Service Provision Asses...

Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.

The purpose of this review is to highlight the key issues with regard to the value, affordability, and availability of diabetes treatments.

Pharmaceutical Services and comprehensiveness 30 years after the advent of Brazil's Unified Health System.

This article examines pharmaceutical services and access to essential medicines in Brazil during the 30 years since the advent of Brazil's Unified Health System from a comprehensiveness perspective. T...

Clinical Trials [2988 Associated Clinical Trials listed on BioPortfolio]

Differences Between Essential Medicines Lists in 135 Countries and Model List of Essential Medicines

The World Health Organization (WHO) has developed a model list of more than 400 medicines and recommends that each country adapt the list to its own circumstances. More than 100 countries ...

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Countries throughout the world are facing a growing non-communicable disease (NCD) burden. In developing countries, medicines to treat NCDs are often difficult to access or too expensive f...

Carefully seLected and Easily Accessible at No Charge Medications Randomized Controlled Trial

This trial evaluates the effect of providing primary care patients with free and convenient access to a set of essential medicines. Half of the participants will receive free and convenien...

Metabolism of Lipids in Advanced Cancer

The causes of failing nutrition status in advanced cancer are not well known. The way fat is moved, stored, burned or changed into other compounds may be affected and will be followed in p...

Metabolic Availability of Lysine From Millet in Adult Men

Protein is the key determinant of growth and bodily functions. The quality of food proteins depend on their amino acid content and the amount of amino acids used by the body to make protei...

Medical and Biotech [MESH] Definitions

Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).

Countries known in remote history (as BYZANTIUM) or former names of countries reflecting political changes in the 20th century (as GERMANY, EAST).

Countries that have reached a level of economic achievement through an increase of production, per capita income and consumption, and utilization of natural and human resources.

A 180-kDa VEGF receptor found primarily in endothelial cells that is essential for vasculogenesis and vascular maintenance. It is also known as Flt-1 (fms-like tyrosine kinase receptor-1). A soluble, alternatively spliced isoform of the receptor may serve as a binding protein that regulates the availability of various ligands for VEGF receptor binding and signal transduction.

A condition of suboptimal concentration of SPERMATOZOA in the ejaculated SEMEN to ensure successful FERTILIZATION of an OVUM. In humans, oligospermia is defined as a sperm count below 20 million per milliliter semen.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Searches Linking to this Article